Clinical Trials Directory

Trials / Recruiting

RecruitingNCT04285125

High Resolution Imaging for Analysis of MVNT

High Resolution Imaging for Analysis of Multinodular and Vacuolating Neuronal Tumor of the Cerebrum

Status
Recruiting
Phase
Study type
Observational
Enrollment
33 (estimated)
Sponsor
Fondation Ophtalmologique Adolphe de Rothschild · Network
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

MVNT (multinodular and vacuolating neuronal tumor of the cerebrum) is a benign, recently discovered, neuronal lesion, the incidence of which is unknown. It seems to predominate in the temporal lobes and presents a characteristic MRI appearance: multiple subcortical nodules, developed at the white substance / gray substance junction, of variable size, well limited, in iso-hyposignal T1, hypersignal T2 and hypersignal FLAIR. The articles describing this entity report the lack of scalability in MRI during patient monitoring, going in the direction of the benignity of the lesion. The diagnosis sometimes remains uncertain with current MRI sequences, and the patient risks undergoing invasive surgery to remove a lesion that is actually benign. Hence the importance of developing the most precise diagnostic criteria possible. The contribution of advanced MRI techniques, such as ultra-high resolution sequences in the characterization of these lesions, has not yet been studied.

Conditions

Interventions

TypeNameDescription
OTHERcerebral MRIPatients who agree to participate in the study will perform an MRI with ultra high resolution sequences added by the research MRI of control will be done at one year and two years

Timeline

Start date
2020-03-05
Primary completion
2025-05-19
Completion
2027-05-19
First posted
2020-02-26
Last updated
2026-01-05

Locations

7 sites across 1 country: France

Source: ClinicalTrials.gov record NCT04285125. Inclusion in this directory is not an endorsement.